Skip to main content
eScholarship
Open Access Publications from the University of California

Acute exacerbation of carpal tunnel syndrome after Radiesse® injection for hand rejuvenation.

  • Author(s): Feig, JL
  • Ho, AM
  • Isseroff, RR
  • et al.

Published Web Location

https://onlinelibrary.wiley.com/doi/abs/10.1111/bjd.17132
No data is associated with this publication.
Creative Commons 'BY-NC' version 4.0 license
Abstract

A calcium hydroxyapatite filler (CaHA, Radiesse® ; Merz Aesthetics, Franksville, WI, USA) became the first FDA-approved injectable filler for volume loss correction of the dorsal hands during rejuvenation.1 Within three months, the filler is processed by macrophage phagocytosis, and CaHA stimulates neocollagenesis for sustained results. The material does not stimulate calcifications or foreign body reactions, and allergy testing is not required. In fact, its chemically inert behavior contributes to its high degree of biocompatibility and favorable safety profile. Marmur et al. reported no long-term adverse events at 6 month follow-up. This article is protected by copyright. All rights reserved.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item